Table 1.

Characteristics of two groups.

Group		Name	Clinical Stage	Age	MeCP2 Mutation	Level 1 of Severity
Non-sham	1	M.R.	IV	35	T158M	Moderate
tDCS	2	A.S.	III	13	c.1566_1197 del41	Moderate
	3	S.B.	III	20	c.916C>T	Mild
	4	N.R.	IV	29	R255C	Moderate
	5	T.C.	III	18	R270X	Moderate
	6	G.V.	III	13	R255C	Mild
	7	S.B.	IV	31	R255C	Moderate
	8	S.C.	III	16	T158M	Moderate
	9	R.O.	III	19	R270X	Severe
	10	S.M.	III	18	C.916C>T	Moderate
	11	P.S.	III	15	R255X	Moderate
	12	C.A.	III	19	PT158M	Moderate
	13	T.M.	III	26	R270X	Moderate
	14	V.A.	III	15	R294X	Moderate
	15	E.M.	III	14	R270X	Moderate
	16	E.P.	IV	29	P.R135C	Mild
	17	M.L.	III	25	p.Pro322Leu	Moderate
	18	C.T.	III	17	R270X	Moderate
Sham	19	S.L.	III	18	p.R133C	Mild
tDCS	20	M.G.	III	17	R168X	Mild
	21	V.A.	IV	35	R270X	Mild
	22	M.B.	III	18	C.916C>T	Moderate
	23	A.L.	III	17	T158M	Severe
	24	R.S.	III	21	R168X	Moderate
	25	S.P.	III	16	168RX	Moderate
	26	R.B.	III	18	R270X	Moderate
	27	M.C.	III	19	R168X	Moderate
	28	C.S.	III	13	R306C	Moderate
	29	V.S	III	16	R133C	Moderate
	30	Z.F	III	14	P322A	Moderate
	31	G.S.	III	19	R255C	Moderate